Yusheng Han

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Liquid biopsy-based multi-omics approach for early detection of hepatocellular carcinoma (ASCEND-Hep): a multiphase prospective development and validation study.

Liquid biopsy-based multi-omics approach for early detection of hepatocellular carcinoma (ASCEND-Hep): a multiphase prospective development and validation study.

Journal: BMC medicine

Published: January 07, 2026

Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective.

Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective.

Journal: Cancer reports (Hoboken, N.J.)

Published: June 06, 2024

A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma.

A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma.

Journal: Cancer investigation

Published: April 14, 2024

Performance of Liquid Biopsy-Based Multi-Omics Biomarkers for Early Detection of Gynecological Malignancies: A Prospective Study (PERCEIVE-I).

Performance of Liquid Biopsy-Based Multi-Omics Biomarkers for Early Detection of Gynecological Malignancies: A Prospective Study (PERCEIVE-I).

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 19, 2024

A differentially-methylated-region signature predicts the recurrence risk for patients with early stage lung adenocarcinoma.

A differentially-methylated-region signature predicts the recurrence risk for patients with early stage lung adenocarcinoma.

Journal: Aging

Published: October 10, 2023

MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.

MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.

Journal: Aging

Published: August 15, 2023

IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers.

IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers.

Journal: Clinical and translational medicine

Published: June 08, 2023

Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer.

Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer.

Journal: Aging

Published: March 04, 2023

Development and validation of an inflammatory response-related gene and clinical factor-based signature for predicting prognosis in gastric cancer.

Development and validation of an inflammatory response-related gene and clinical factor-based signature for predicting prognosis in gastric cancer.

Journal: Journal of gastrointestinal oncology

Published: January 31, 2023

A DNA Damage Response Related Signature to Predict Prognosis in Patients with Acute Myeloid Leukemia.

A DNA Damage Response Related Signature to Predict Prognosis in Patients with Acute Myeloid Leukemia.

Journal: Cancer investigation

Published: January 11, 2023

A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma.

A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma.

Journal: iScience

Published: January 06, 2023

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma.

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: October 31, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026